Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

FDA Approves Same Day 2nd Eye Laser Treatment

Facebook X LinkedIn Email
FREMONT, Calif., July 21 -- Sunrise Technologies International, Inc. reports that it has received conditional approval from the US Food and Drug Administration to treat both patients' eyes on the same day as part of its ongoing US clinical trials of the company's laser thermal keratoplasty (LTK) treatment. LTK is used to treat mid-hyperopia, or farsightedness, from +2.75 to +4.0 diopters; the company estimates that nearly 90 percent of all hyperopes over age 40 fall under the four diopters limit. FDA approval allows for treatment of the second eye of the current subjects as well as treatment...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: July 1999
    News & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.